Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial

2020430 citationsJournal Articlehybrid Open Access

Authors

Maryam Edalatifard · Tehran University of Medical Sciences

Maryam Akhtari · Zero to Three

Mohammadreza Salehi · Tehran University of Medical Sciences

Zohre Naderi · Isfahan University of Medical Sciences

Ahmadreza Jamshidi · Tehran University of Medical Sciences

Shayan Mostafaei · Kermanshah University of Medical Sciences

Seyed Reza Najafizadeh

Abstract

Our results suggest that methylprednisolone pulse could be an efficient therapeutic agent for hospitalised severe COVID-19 patients at the pulmonary phase.

Topics & Keywords

Long-Term Effects of COVID-19 COVID-19 Clinical Research Studies Pathogenesis and Treatment of Hiccups

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Respiratory Journal

Volume 56, Issue 6, pp. 2002808-2002808

DOI: 10.1183/13993003.02808-2020

Field-Weighted Citation Impact: 33.77